Building Blocks

Versatile small molecule scaffold

4-Bromo-1,2-bis(trifluoromethyl)benzene is a reactive intermediate that can be used in the synthesis of other chemical compounds. It has been shown to react with cysteine residues and amino acid side chains, leading to covalent modifications in proteins. 4-Bromo-1,2-bis(trifluoromethyl)benzene is also used as a tool for screening chemical biology strategies and drug discovery.

Versatile small molecule scaffold

Pyrido[2,3-b]pyrazine is a sulfa drug that belongs to the group of drugs containing sulfur. It is an inhibitor of bacterial growth that binds to the nitrogen atom in the bacterial cell wall, thereby preventing coordination geometry and inhibiting growth. Pyrido[2,3-b]pyrazine has been shown to be active against cancer cells and has synergistic effects when used with other agents such as hydrochloric acid or trifluoroacetic acid. The binding of pyrido[2,3-b]pyrazine to the cell surface can disrupt receptor function and inhibit the production of certain growth factors. Pyrido[2,3-b]pyrazine also chelates metal ions such as iron and copper ions which are essential for bacterial metabolism.

Methyl benzo[d][1,3]dioxole-5-carboxylate is a prodrug of the active form, benzo[d][1,3]dioxole-5-carboxylic acid. It is used in the treatment of bowel disease and can be administered orally or intravenously. Methyl benzo[d][1,3]dioxole-5-carboxylate works by inhibiting the proteolytic enzymes that digest proteins in the small intestine. This drug has been shown to have an optimum concentration of 10-20 mg/mL when incubated with human ileal tissue. Methyl benzo[d][1,3]dioxole-5-carboxylate has also been shown to inhibit the activity of several inflammatory enzymes such as cyclooxygenase and lipoxygenase. This drug also has a protective effect on the lungs by inhibiting expiratory flow and clearing out

2-(2-Fluorophenyl)acetamide is a nucleoside analogue that inhibits the activity of thymidine kinase, which is an enzyme that converts thymine to deoxyuridine monophosphate and vice versa. 2-(2-Fluorophenyl)acetamide has been shown to be effective against herpes simplex virus and is a lead compound for the development of antiviral compounds. This drug is not toxic to cells and has no adverse side effects.

N-(2-fluoro-4-methylphenyl)acetamide (FMAA) is a sterically hindered, regioselective amine brominating agent. FMAA has shown high efficiency in the conversion of anilides to bromides. FMAA is also very efficient in orienting the substrates for bromination and can be used to prepare N-(2-bromo-4-methylphenyl)acetamide. The selectivity of this reagent is due to its steric effect that prevents the substrate from reacting with other functional groups on the molecule. FMAA has been successfully used in the synthesis of 2-[(2,6-dichlorophenyl)amino]-N-(2,4,6-trimethylphenyl)acetamide and 2-[(3,5-dichlorophenyl)amino]-N-(3,5,6-trimethylphenyl)acetamide.

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold